As of 9:45am ET
| 0.0001 / +0.02%|
The 2 analysts offering 12-month price forecasts for Protalix Biotherapeutics Inc have a median target of 2.15, with a high estimate of 3.50 and a low estimate of 0.80. The median estimate represents a +270.69% increase from the last price of 0.58.
The current consensus among 2 polled investment analysts is to Buy stock in Protalix Biotherapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.